Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/05/2008 | CA2671217A1 New a.beta. conformer selective anti-a.beta. globulomer monoclonal antibodies |
06/05/2008 | CA2670967A1 Alternative export pathways for vector expressed rna interference |
06/05/2008 | CA2670790A1 Polypeptides comprising fas activation and nkg2d-ligand domains |
06/05/2008 | CA2670757A1 Electroporation cuvette with high field intensity and field-induced agitation |
06/05/2008 | CA2670626A1 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter tm1040 |
06/05/2008 | CA2670622A1 Nucleic acid probes and methods for detecting plasmodium parasites |
06/05/2008 | CA2670588A1 Evolved orthogonal ribosomes |
06/05/2008 | CA2670583A1 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
06/05/2008 | CA2670563A1 Methods for treating hypercholesterolemia |
06/05/2008 | CA2670471A1 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
06/05/2008 | CA2670447A1 Nuclease-resistant rna aptamer inhibiting replication of hepatitis c virus replicon |
06/05/2008 | CA2670445A1 Binding members for interleukin-6 |
06/05/2008 | CA2670163A1 Viral vector and its applications |
06/05/2008 | CA2668932A1 Modified soluble fgf receptor fc fusions with improved biological activity |
06/05/2008 | CA2664809A1 Soybean gene for resistance to aphis glycines |
06/04/2008 | EP1927665A2 Methods and kits for diagnosing and treating b-Cell chronic lymphocytic leukemia (B-CLL) |
06/04/2008 | EP1927661A2 Anti-listeria bacteriocin |
06/04/2008 | EP1927660A2 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
06/04/2008 | EP1927659A1 Wisp polypeptides and therapeutical applications thereof |
06/04/2008 | EP1927598A1 Vaccine |
06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
06/04/2008 | EP1926835A2 Message abundance and allele copy number determination using ivt with single-stranded primer-promoter-selector constructs |
06/04/2008 | EP1926820A2 A new selection system for wheat |
06/04/2008 | EP1926819A1 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification |
06/04/2008 | EP1926818A2 Nitrate transport components |
06/04/2008 | EP1926817A2 Human coagulation factor vii polypeptides |
06/04/2008 | EP1926816A1 In vivo generation of dna, rna, peptide, and protein libraries |
06/04/2008 | EP1926815A1 Method for the selective enrichment of double-stranded dna from nucleic acid mixtures |
06/04/2008 | EP1926814A1 Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer |
06/04/2008 | EP1926753A2 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate-binding module as second amino acid sequence |
06/04/2008 | EP1926750A2 Biological materials and uses thereof |
06/04/2008 | EP1926747A1 Mcp1 fusions |
06/04/2008 | EP1926745A1 Gene encoding cell wall mannoprotein and use thereof |
06/04/2008 | EP1926365A1 Red lettuce |
06/04/2008 | EP1580267B1 Gene improving temperature-tolerance of acetic acid bacterium, acetic acid bacterium bred using the gene and process for producing vinegar using the acetic acid bacterium |
06/04/2008 | EP1522039B1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
06/04/2008 | EP1476549B1 Methods for two-dimensional conformation-dependent separation of non-circular nucleic acids |
06/04/2008 | EP1463754B1 Cystine-knot fold protein |
06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
06/04/2008 | EP1390533B1 Analytical method and kit |
06/04/2008 | EP1354951B1 Method of examining ability to control nerve cell plasticity |
06/04/2008 | EP1347056B1 Gene encoding acetolactate synthase |
06/04/2008 | EP1322327B1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
06/04/2008 | EP1283888B1 Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri |
06/04/2008 | EP1192182B1 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
06/04/2008 | EP1185658B1 Novel compounds from moraxella catarrhalis |
06/04/2008 | EP1151304B9 METHOD OF IDENTIFYING N-TERMINAL proBNP |
06/04/2008 | EP1146959B1 Apparatus for liposome production |
06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
06/04/2008 | EP1005534B1 Method for increasing the efficiency of recombinant aav production |
06/04/2008 | EP0990703B1 Novel polypeptide, dna encoding the same and use thereof |
06/04/2008 | EP0958305B1 Inhibitions of the interaction between p53 and mdm2 |
06/04/2008 | EP0946199B1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW |
06/04/2008 | EP0920505B1 Mammalian cell surface antigens; related reagents |
06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
06/04/2008 | CN101194166A Materials and methods relating to breast cancer classification |
06/04/2008 | CN101194020A Process for production of L-amino acid |
06/04/2008 | CN101194018A Site-specific serine recombinases and methods of their use |
06/04/2008 | CN101194017A Conjugate comprising p21 protein for the treatment of cancer |
06/04/2008 | CN101194013A Novel sesquiterpene synthases and methods of their use |
06/04/2008 | CN101193906A Mannitol induced promoter systems in bacterial host cells |
06/04/2008 | CN101193655A Vaccine against pandemic strains of influenza viruses |
06/04/2008 | CN101193654A Antigen conjugates and uses thereof |
06/04/2008 | CN101193653A Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies |
06/04/2008 | CN101193646A Methods for treating infectious disease exacerbated asthma |
06/04/2008 | CN101193550A Methods of producing and growing plants having improved phosphorus utilization |
06/04/2008 | CN101191146A Primer for bacterium genome amplification reaction |
06/04/2008 | CN101191144A Method for identifying and distinguishing useful yew correlated with taxane content |
06/04/2008 | CN101191133A Carrier for catching secretion sequence and its construction method and application thereof |
06/04/2008 | CN101191132A Molecule mark linked to cabbage green bolting gene and establishing method thereof |
06/04/2008 | CN101191131A Triticum timopheevi high molecular weight glutelin Gy7* gene and application thereof |
06/04/2008 | CN101191130A ChIFNGR1 gene and its coding protein and application |
06/04/2008 | CN101191129A Gene engineering domestic silkworm antibiotic peptide and its preparation method and application |
06/04/2008 | CN101191128A Method and apparatus for disrupting cells and purifying nucleic acid using a single chamber |
06/04/2008 | CN101191127A Tomato explant highly effective conversion system induced by agrobacterium |
06/04/2008 | CN101190946A Recombination plasmodium falciparum circumsporozoite surface protein and its preparation method and use |
06/04/2008 | CN101190945A Preparation for specificity anticoagulant substance and application thereof |
06/04/2008 | CN101190944A Human cytokine and use thereof |
06/04/2008 | CN100392099C Method for immobilizing a biomolecule on a solid substrate at a high density by using the substrate having an activated carboxyl group on a surface thereof and microarray produced using the method |
06/04/2008 | CN100392097C Method of detecting nucleic acid by using DNA microarrays and nucleic acid detection apparatus |
06/04/2008 | CN100392087C Flavivirus vaccine delivery system |
06/04/2008 | CN100392086C High level production of P-hydroxybenzoic acid in green plants |
06/04/2008 | CN100392085C Vaccines |
06/04/2008 | CN100392084C Recombinant adenovirus containing codon optimized type IIPV16L1 gene |
06/04/2008 | CN100392083C DNA encoding ovine adenovirus (OAV 287) and its use as a viral vector |
06/04/2008 | CN100392082C Conserved neisserial antigens |
06/04/2008 | CN100392081C Wheat WRAB 17 gene promotor and application thereof |
06/04/2008 | CN100392080C Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
06/04/2008 | CN100392079C Protein C or activated protein C-like molecules |
06/04/2008 | CN100392077C Carbohydrate oxidase and use thereof in baking |
06/04/2008 | CN100392075C Glutamine synthetase and its dedicated expression engineered bacteria and uses |
06/04/2008 | CN100392071C Engineered bacterium lacking lactic acid production path and its construction method and uses |
06/04/2008 | CN100392070C High efficiency experssino human glicentin-1 gene engineering bacteria and its construction method and use |
06/04/2008 | CN100392069C Production of D-pantoic acid and D-pantothenic acid |
06/04/2008 | CN100391978C Recombinant anti-CD4 antibodies for human therapy |
06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
06/04/2008 | CN100391976C High efficiency low poison immune toxin and its preparation method and application |
06/04/2008 | CN100391975C Human source anti- tetanus exotoxin antibody and preparation method and use thereof |
06/04/2008 | CN100391974C Recombined collagen and synthesizing and expressing purifying process thereof |